27
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Canadian Open Genetics Repository (COGR): a unified clinical genomics database as a community resource for standardising and sharing genetic interpretations

      research-article
      1 , 2 , 3 , 4 , 5 , 4 , 6 , and the Canadian Open Genetics Repository Group
      (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab),   (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab), (Collab)
      Journal of Medical Genetics
      BMJ Publishing Group
      Genetic screening/counselling, Clinical genetics, Diagnostics tests, Evidence Based Practice, Genetics

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The Canadian Open Genetics Repository is a collaborative effort for the collection, storage, sharing and robust analysis of variants reported by medical diagnostics laboratories across Canada. As clinical laboratories adopt modern genomics technologies, the need for this type of collaborative framework is increasingly important.

          Methods

          A survey to assess existing protocols for variant classification and reporting was delivered to clinical genetics laboratories across Canada. Based on feedback from this survey, a variant assessment tool was made available to all laboratories. Each participating laboratory was provided with an instance of GeneInsight, a software featuring versioning and approval processes for variant assessments and interpretations and allowing for variant data to be shared between instances. Guidelines were established for sharing data among clinical laboratories and in the final outreach phase, data will be made readily available to patient advocacy groups for general use.

          Results

          The survey demonstrated the need for improved standardisation and data sharing across the country. A variant assessment template was made available to the community to aid with standardisation. Instances of the GeneInsight tool were provided to clinical diagnostic laboratories across Canada for the purpose of uploading, transferring, accessing and sharing variant data.

          Conclusions

          As an ongoing endeavour and a permanent resource, the Canadian Open Genetics Repository aims to serve as a focal point for the collaboration of Canadian laboratories with other countries in the development of tools that take full advantage of laboratory data in diagnosing, managing and treating genetic diseases.

          Related collections

          Most cited references7

          • Record: found
          • Abstract: not found
          • Article: not found

          A vision for the future of genomics research.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Charting a course for genomic medicine from base pairs to bedside.

            There has been much progress in genomics in the ten years since a draft sequence of the human genome was published. Opportunities for understanding health and disease are now unprecedented, as advances in genomics are harnessed to obtain robust foundational knowledge about the structure and function of the human genome and about the genetic contributions to human health and disease. Here we articulate a 2011 vision for the future of genomics research and describe the path towards an era of genomic medicine.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The GeneInsight Suite: a platform to support laboratory and provider use of DNA-based genetic testing.

              The future of personalized medicine will hinge on effective management of patient genetic profiles. Molecular diagnostic testing laboratories need to track knowledge surrounding an increasingly large number of genetic variants, incorporate this knowledge into interpretative reports, and keep ordering clinicians up to date as this knowledge evolves. Treating clinicians need to track which variants have been identified in each of their patients along with the significance of these variants. The GeneInsight(SM) Suite assists in these areas. The suite also provides a basis for interconnecting laboratories and clinicians in a manner that increases the scalability of personalized medicine processes. © 2011 Wiley-Liss, Inc.
                Bookmark

                Author and article information

                Journal
                J Med Genet
                J. Med. Genet
                jmedgenet
                jmg
                Journal of Medical Genetics
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                0022-2593
                1468-6244
                July 2015
                22 April 2015
                : 52
                : 7
                : 438-445
                Affiliations
                [1 ]Laboratory Medicine and Pathobiology, University of Toronto & Mount Sinai Hospital , Toronto, Ontario, Canada
                [2 ]Ontario Institute for Cancer Research , Toronto, Ontario, Canada
                [3 ]Department of Pathology and Laboratory Medicine, Mount Sinai Hospital , Toronto, Ontario, Canada
                [4 ]Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine , Cambridge, Massachusetts, USA
                [5 ]Massachusetts General Hospital , Boston, Massachusetts, USA
                [6 ]Brigham and Women's Hospital and Harvard Medical School , Boston, Massachusetts, USA
                Author notes
                [Correspondence to ] Jordan Lerner-Ellis, Laboratory Medicine and Pathobiology, University of Toronto & Mount Sinai Hospital, 600 University Ave, Toronto, Ontario, Canada M5G 1X5; jlerner-ellis@ 123456mtsinai.on.ca
                Article
                jmedgenet-2014-102933
                10.1136/jmedgenet-2014-102933
                4501169
                25904639
                bc15b5f1-bb95-4bbf-83fb-06ce77746f13
                Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

                This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

                History
                : 4 December 2014
                : 9 March 2015
                : 15 March 2015
                Categories
                1506
                Screening
                Original article
                Custom metadata
                unlocked

                Genetics
                genetic screening/counselling,clinical genetics,diagnostics tests,evidence based practice,genetics

                Comments

                Comment on this article